COMMUNIQUÉS West-GlobeNewswire

Statement re Cancellation
02/05/2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION Certain information contained [...]
Biocartis Group NV: BIOCARTIS LAUNCHES CONVERTIBLE BONDS OFFERING OF EUR 125 MILLION
02/05/2019
PRESS RELEASE : REGULATED INFORMATION - INSIDE INFORMATION 2 May 2019, 08:00 CEST BIOCARTIS LAUNCHES CONVERTIBLE BONDS OFFERING OF EUR 125 MILLION Mechelen, Belgium, 2 May 2019 - Biocartis Group NV ("Biocartis" or the " [...]
MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2018
02/05/2019
MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2018 Paris, le 2 mai 2019 – 8h00 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro de spécialité, [...]
AroCell expands its distribution network and signs distribution agreement with Inveniolife
02/05/2019
AroCell AB (publ) announce today that a distribution agreement has been signed with the Mumbai based company Inveniolife Technology Pvt. Ltd. for the promotion and distribution of the AroCell TK 210™ ELISA in India. [...]
DBV Technologies to Attend Upcoming Investor Conferences
02/05/2019
Montrouge, France, May 2, 2019 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, [...]
DBV Technologies invitée à présenter lors de prochaines conférences Investisseurs
02/05/2019
Montrouge, France, le 2 mai (7H30 CET), 2019 DBV Technologies invitée à présenter lors de prochaines conférences Investisseurs DBV Technologies (Euronext: DBV – ISIN : FR0010417345 - Nasdaq Stock Market : DBVT), une [...]
Basilea's partner Avir Pharma has launched antifungal Cresemba® (isavuconazole) in Canada
02/05/2019
Basel, Switzerland, May 02, 2019 – Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its partner Avir Pharma Inc. (“Avir Pharma”) has launched the antifungal Cresemba ® (isavuconazole) in Canada. David Veitch [...]
VALNEVA Reports Strong Q1 2019 Operating Results and Advances Key R&D Programs towards Major Milestones
02/05/2019
Valneva Reports Strong Q1 2019 Operating Results and Advances Key R&D Programs towards Major Milestones Repeated significant growth in IXIARO ® revenues; Lyme disease and chikungunya programs advancing towards major [...]
VALNEVA : très bons résultats opérationnels au T1 2019, avancée des programmes clés vers d'importants jalons R&D
02/05/2019
Valneva : très bons résultats opérationnels au T1 2019, avancée des programmes clés vers d'importants jalons R&D Croissance significative et répétée des ventes d'IXIARO ® ; Avancée des programmes contre la maladie [...]
Lloyd Diamond will serve as Chief Executive Officer of Pixium Vision
02/05/2019
Paris, May 2 nd , 2019 – 07:00 AM CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent [...]
Lloyd Diamond sera nommé Directeur Général de Pixium Vision
02/05/2019
Paris, 2 mai 2019 – 07 : 00 CEST - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue de vivre de façon [...]
Genkyotex Reports Clinical Evidence of Anti-fibrotic Activity by GKT831 in Liver Fibrosis Patients
02/05/2019
Top Line Efficacy Results from Phase 2 Primary Biliary Cholangitis (PBC) Trial 22% reduction in liver stiffness in PBC patients with liver fibrosis compared to a 4% increase for placebo (p=0.038), supports anti-fibrotic [...]
Genkyotex communique sur les données cliniques attestant d'une activité anti-fibrotique du GKT831 chez des patients atteints de fibrose hépatique
02/05/2019
ERN France, 02 mai 2019 (GLOBE NEWSWIRE) -- Genkyotex communique sur les données cliniques attestant d'une activité anti-fibrotique du GKT831 chez des patients atteints de fibrose hépatique
TransMedics Announces Pricing of Upsized Initial Public Offering
02/05/2019
ANDOVER, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc., a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, (“ [...]
Precipio Reminder of Corporate Update Shareholder Call
02/05/2019
Conference Call to be held Monday May 6th, 2019 at 5:00pm Eastern Time NEW HAVEN, Conn., May 01, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), will host a conference call on [...]
Tetra Bio-Pharma Closes the Acquisition of Panag Pharma
01/05/2019
OTTAWA, May 01, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the " Company "), a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that [...]
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
01/05/2019
EMERYVILLE, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it has issued inducement awards to nine new non- [...]
Flexion Therapeutics to Report First-Quarter 2019 Financial Results on May 8, 2019
01/05/2019
BURLINGTON, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its first-quarter 2019 financial results after the close of the U.S. financial markets on [...]
Innovate Biopharmaceuticals Announces Closing of $8.7 Million Registered Direct Offering
01/05/2019
RALEIGH, N.C., May 01, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) today announced the closing of its previously announced registered direct offering of 4,318,272 shares of common stock at [...]

Pages